1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Real World Evidence Solution Market, by Component
6.1. Introduction
6.2. Data Set
6.2.1. Claims Data
6.2.2. Clinical Settings Data
6.2.3. Patient-Powered Data
6.2.4. Pharmacy Data
6.3. Services

7. Real World Evidence Solution Market, by Therapeutic Area
7.1. Introduction
7.2. Cardiovascular
7.3. Immunology
7.4. Infectious Diseases
7.5. Neurology
7.6. Oncology

8. Real World Evidence Solution Market, by End-User
8.1. Introduction
8.2. Biopharmaceutical Company
8.3. Clinical & Life Sciences Organization
8.4. Diagnostics or Medical Device Company

9. California Real World Evidence Solution Market

10. Florida Real World Evidence Solution Market

11. Illinois Real World Evidence Solution Market

12. New York Real World Evidence Solution Market

13. Ohio Real World Evidence Solution Market

14. Pennsylvania Real World Evidence Solution Market

15. Texas Real World Evidence Solution Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Certara, L.P.
17.2. Clinigen Group PLC
17.3. Cognizant Technology Solutions Corp.
17.4. HealthiVibe, LLC
17.5. IBM Corporation
17.6. ICON PLC
17.7. IQVIA
17.8. Mercy Technology Services
17.9. Oracle Corporation
17.10. PAREXEL International Corporation
17.11. Pharmaceutical Product Development, LLC
17.12. SAS Institute, Inc.
17.13. Sciformix Corporation
17.14. Syneos Health
17.15. Turacoz

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2026
FIGURE 7. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (%)
FIGURE 20. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2026
FIGURE 22. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 32. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 33. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2026
FIGURE 35. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: FPNV POSITIONING MATRIX
FIGURE 42. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 43. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: SCORES
TABLE 22. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: BUSINESS STRATEGY
TABLE 23. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 24. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: RANKING
TABLE 25. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 26. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: MERGER & ACQUISITION
TABLE 27. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 28. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 29. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 30. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 31. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET: LICENSE & PRICING

Companies Mentioned

Certara, L.P.
Clinigen Group PLC
Cognizant Technology Solutions Corp.
HealthiVibe, LLC
IBM Corporation
ICON PLC
IQVIA
Mercy Technology Services
Oracle Corporation
PAREXEL International Corporation
Pharmaceutical Product Development, LLC
SAS Institute, Inc.
Sciformix Corporation
Syneos Health
Turacoz